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Objectives: To evaluate the utility and efficacy of colour-coded uplex scanning as an adjunct o clinical surveillance of 
infrainguinal vein bypass urgery. 
Design: Prospective controlled randomised trial. 
Methods: The trial included 179 consecutive patients undergoing 185 primary infrainguinaI vein graft reconstructions 
during a 3-year period. Patients alive without amputation and with open graft at 1 month were randomised to a 
surveillance program based on clinical examination and ankle-brachiaI pressure index measurement (ABI group) or 
additional duplex scanning (DD group). All patients were scheduled for surveillance at 1, 3, 6, 9 and 12 months after 
operation. 
Results: Surveillance identified four failing grafts in the ABI group and 11 in the DD group which were revised. The 
number of occluded grafts was seven in ABI group and 12 in DD group. At 1-year overall cumulative assisted primary 
patency rates in the ABI group and in the DD group were 74% and 65% respectively (p = 0.21), corresponding secondary 
patency rates were 84% and 71% (p=O.04) and limb salvage rates 88% versus 81% (p=0.23) respectively. 
Conclusions: This study failed to show any beneficial effect of duplex scanning in a surveillance program, which was 
difficult to accomplish as a part of routine clinical work. However, the main difference in outcome appeared uring the 
first postoperative month before the commencement of he surveillance program. 
Key Words: Vein graft; Duplex scanning; Surveillance; Randomised study. 
Introduction 
The failure rate of jnfrainguinal bypass procedures 
has remained a matter of concern in modern vascular 
surgery despite increasing experience and technical 
advances. During the first postoperative month 4-30% 
of vein grafts occluded, 1-5 either due to poor selection 
or intraoperative t chnical errors and misjudgement. 
Intermediate failure up to 2 years is mainly caused by 
stenotic lesions developing in the graft or anastomotic 
areas due to neointimal hyperplasia. In Szilagyi's clas- 
sical angiographic study 33% grafts developed sten- 
oses in 5 years 6and in more recent studies it has been 
shown that 16-30% of grafts develop stenoses within 
2 years. 7-11 Non-invasive periodic graft surveillance 
especially during the first 2 years after surgery has 
been reported to improve overall graft patency and 
limb salvage by identifying stenotic lesions and al- 
lowing intervention before occlusion occurs. 12-14 There 
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is data to suggest that only a 1-year follow up is likely 
to be beneficial as the risk of occlusion during the 
second year is much lower. 9 In experienced hands 
colour-flow duplex scanning has been shown to be an 
accurate tool in detecting vein graft stenosis 1s-17 and 
is generally believed to be the best method for vein 
graft surveillance. However, none of the data presented 
in favour of duplex surveillance over other non-in- 
vasive methods is based on direct evidence of a com- 
parative trial. The only randomised study in favour 
of an intensive surveillance program found im- 
provement of 25% in assisted primary patency rate 
compared with routine clinical follow-up, but the posi- 
tive effect achieved could be due to the intensity 
of the programme rather than due to the choice of 
surveillance methods. I8 The aim of this trial was to 
assess the impact of duplex scanning in the sur- 
veillance program. 
Materials and Methods 
All patients undergoing primary infrainguinal re- 
constructions with autologous vein in the Division of 
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Vascular Surgery, Helsinki University Central Hos- 
pital, from January 1991 to December 1993 were in- 
cluded. Indications for surgical procedures were 
critical leg ischaemia (defined as rest pain >2 weeks, 
ischaemic ulcer or gangrene of any part of the foot), 
severe intermittent claudication or symptomatic pop- 
liteal aneurysm. Preoperative xaminations included 
angiography, chest X-ray an d electrocardiographic ex-
amination. Patients were operated under epidural an- 
aesthesia. Autologous vein was used as a graft material 
mostly by the in situ saphenous vein technique. 
Patients with prosthetic graft material were excluded 
from the study. Vancomycin was given as antibiotic 
prophylaxis. Grafts were monitored intraoperatively 
by on-table angiography. In the immediate post- 
operative period the ankle pressure was measured 
and ABI calculated. No duplex studies were performed 
prior to discharge. 
Patients were randomised at the time of operation 
according to the date of birth in two different sur- 
veillance groups. Patients born on odd days were 
enrolled to a surveillance program with clinical ex- 
amination and ankle-brachial index measurement 
(ABI-group). For patients born on even days duplex 
scans were added to the above at control visits (DD- 
group). 
at sites proximal, distal and within the area of ab- 
normal flow were made in addition to routine meas- 
urements. 
Intervention criteria 
Intervention criteria included clinical signs of a failing 
graft such as onset of disabling claudication, ischaemic 
pain or ischaemic ulcers and decrease in ABI of 0.15 
or more compared to the immediate postoperative 
ABI. Duplex scanning criteria for further investigation 
were a peak systolic flow velocity (PSV) in distal graft 
<45 cm/s or PSV ratio (velocity at the site of stenosis; 
V2/velocity at normal adjacent graft; V1) >2. Patients 
fulfilling any of these intervention criteria underwent 
angiography. 
Revision 
Angiography-verified stenoses of more than 50% dia- 
meter reduction underwent revision. Vein segment 
interposition or angioplasty with a vein patch was 
used in all cases. Identified arteriovenous fi tulas were 
also ligated. 
Surveillance 
Surveillance was done during the outpatient visits 1, 
3, 6, 9, and 12 months after the operation. Patients 
who were alive, not amputated and with open grafts 
on first control visit were included in the study groups, 
whereas occlusions within the first month were re- 
garded as technical errors. 
Graft occlusion 
Graft occlusion was suspected when a sudden onset 
of critical leg ischaemia and loss of palpable graft 
pulses occurred. The diagnosis was verified either 
with duplex or angiography as necessary. 
Duplex 
The duplex scans were performed by radiologists. An 
ATL Ultramark 9 colour duplex scanner (Advanced 
Technology Laboratories, Stevenage, U.K.) with 
7.5 MHz transducer was used. Patients were examined 
in supine position. The whole graft including proximal 
and distal anastomoses a well as adjacent in- and out- 
flow vessels was examined. Pulsed Doppler spectral 
waveform analysis was performed at several points 
on the course of the graft. If evidence of a flow 
disturbance was detected on colour flow image or 
spectral waveform, recordings of peak flow velocities 
Patient groups 
A total of 185 grafts in 179 patients were originally 
included in this study. Ninety grafts in 86 patients 
were randomized to the ABI group and 95 grafts in 
93 patients to the DD group. During the first post- 
operative month six grafts (7%) in the ABI group and 
14 (16%) in the DD group occluded. Seven and five 
patients respectively died and one patient in the ABI 
group was amputated with an open graft leaving 76 
grafts in each group for analysis of surveillance results. 
There was no difference between the groups re- 
garding age, sex distribution, presence of risk factors 
or indication for surgical procedure (Table 1). Mean 
preoperative ankle-brachial index was 0.51 (95% CI 
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Table 1. Risk factors and indication for operation. 
ABI group DD group Statistical difference 
Grafts 76 76 N.S. 
Mean age (years) 69.8 68.8 N.S. 
Sex 
Female 20 29 
Male 56 47 N.S. 
Diabetes 27 28 N.S. 
Cardiac risk 39 33 N.S. 
Cerebrovascular disease 8 13 N.S. 
Previous vascular operation 36 24 N.S. 
Indication 
Critical leg ischaemia 62 66 N.S. 
Intermittent claudication 11 9 N.S. 
Popliteai aneurysm 3 1 
Table 2. Type of reconstruction and graft material. 
ABI group DD group 
In situ vein 58 60 
Femoropopliteai 18 19 
Femorocrural 27 31 
Femoropedal 13 10 
Ex situ vein 18 16 
Femoropopliteal 8 8 
Femorocrural 3 4 
Femoropedal 7 4 
0.43-0.60) in the ABI group and 0.43 (95% CI 0.38-0.48) 
in the DD group, p = 0.522. The type of surgical pro- 
cedure did not differ between the groups (Table 2). 
The postoperative ABI at discharge was 0.84 (95% 
CI 0.78-0.90) and 0.87 (95% CI 0.81-0.94), p=0.517, 
respectively. 
Statistical analysis 
Analysis of results was done on an intention-to-treat 
basis. Patients who died, whose grafts occluded or 
whose legs were amputated with an open graft during 
the first postoperative month were excluded from the 
analysis of surveillance impact on patency but were 
taken into account when reporting overall patency 
rates. Primary, assisted primary and secondary pat- 
ency rates as well as limb salvage rates (as defined by 
the Ad Hoc Committee on Reporting Standards 19) were 
determined by the life table method. 
Data was analysed using a SPSS for Windows (Ver- 
sion 7.0; SPSS Inc., Chicago, Ill.). Comparisons between 
individual-dependent ca egorical variables were per- 
formed by use of Pearson's Chi-squared analysis and 
Fisher's exact est. Life-table data were compared with 
Wilcoxon's (Gehan) log rank test. The p values less 
than 0.05 were considered significant. 
Results 
Accomplishment of the surveillance program 
In the ABI group 247 (76%) out of 325 planned control 
visits were carried out whereas in the DD group 
corresponding numbers were 281 (81%) out of 346. 
However, only 170 (60%) duplex scans were done in 
the DD group and in the ABI group 20 (8%) duplex 
scans, which were not planned in the study protocol, 
were done based on clinical decision. Twenty-two 
different radiologists did the duplex scans and 39% of 
the scans were performed by trainees under super- 
vision (Table 3). The mean number of control visits 
was 3.25 and 3.70 respectively. Four patients both in 
the ABI group in the DD group were lost to follow- 
up during the 1-year experience. Three patients in the 
ABI group and one patient in the DD group were 
amputated with open grafts during the follow-up. 
Graft stenoses 
Seven angiograms were done in the ABI group and 
15 in the DD group as suggested by intervention 
criteria. In the ABI group angiography verified four 
threatened grafts which were revised. None of them 
occluded uring follow-up period. In the DD group, 
surveillance identified 11 threatened grafts which were 
revised. Two of them occluded later on. 
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Life table 1. Primary patency. 
Interval No. at risk 
(too) 
No. failed 
ABI group 
No. 
wi thdrawn 
Interval 
patency rate 
Cumulat ive 
patency rate 
(O/o) 
Standard 
error 
(%) 
0-1 90 17 8 0.80 
1-3 65 6 4 0.90 
3-6 55 2 4 0.96 
6-9 49 1 3 0.98 
9-12 45 0 2 1.00 
DD group 
Interval No. at risk No. failed No. 
(mo) wi thdrawn 
Interval 
patency rate 
80 
73 
70 
68 
68 
Cumulat ive 
patency rate 
(%) 
5.2 
Standard 
error 
(%) 
0-1 95 22 5 0.76 76 
1-3 68 8 2 0.88 67 
3-6 58 4 2 0.93 62 
6-9 52 4 3 0.92 57 
9-12 45 1 3 0.98 56 5.3 
Life table 2. Assisted primary patency. 
Interval No. at risk 
(too) 
No. failed 
ABI group 
No. 
wi thdrawn 
Interval 
patency rate 
Cumulat ive 
patency rate 
(%) 
Standard 
error 
(%) 
0-1 90 
1-3 66 
3-6 58 
6-9 52 
9-12 49 
Interval No. at risk 
(too) .... 
16 8 0.82 
4 4 0.94 
2 4 0.96 
1 2 0.98 
0 2 1.00 
DD group 
No. failed No. 
wi thdrawn 
Interval 
patency rate 
82 
78 
76 
74 
74 
Cumulat ive 
patency rate 
(%) 
4.9 
Standard 
error 
(%) 
0-1 95 19 5 0.79 79 
1-3 71 7 2 0.90 72 
3-6 62 1 3 0.98 70 
6-9 58 3 3 0.95 67 
9-12 52 1 4 0.98 65 5.1 
Graft occlusion 
Seven grafts occluded in the ABI group and 12 in the 
DD group during the surveillance period. The median 
time to graft occlusion from primary surgical pro- 
cedure in the ABI group was 186 days (range 69-270 
days) and in the DD group 202 days (range 87-365 
days). The mean duration from the last outpatient visit 
to occlusion was 95 days (range 12-183 days) in the 
ABI group and 57 days (range 22-135 days) in the DD 
group (p = 0.299). In the ABI group a decrease in ABI 
was seen and a graft stenosis in duplex was suspected 
in one patient, but the graft was found to be occluded 
in angiography 36 days after the duplex examination. 
In the DD group one patient had a patch angioplasty 
of a stenosis in the distal anastomosis. At the next 
outpatient visit a low-flow state could still be seen in 
distal vein graft but this was neglected with sub- 
sequent graft occlusion. In a re-evaluation of the du- 
plex examinations of those 12 grafts that eventually 
failed in the DD-group, four grafts that did not fulfill 
intervention criteria had a marked rise in end-diastolic 
velocity (EDV), which exceeded 20 cm/s in three cases 
(Table 4). 
Graft patency 
The overall 1-year primary patency rate was 68% in 
the ABI group versus 56% in the DD group (p=0.11), 
assisted primary patency rate 74% versus 65% (p = 
0.21) and secondary patency 84% versus 71% re- 
spectively (p = 0.04) (Figs 1-3). The type of surveillance 
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Life table 3. Secondary patency. 
Interval No. at risk 
(too) 
No. failed 
ABI group 
No. 
wi thdrawn 
Interval 
patency rate 
Cumulat ive 
patency rate 
(%) 
Standard 
error 
(%) 
0-1 
1-3 
3-6 
6-9 
9-12 
Interval 
(mo) 
90 6 8 0.93 
76 4 5 0.94 
67 2 4 0.97 
61 1 3 0.98 
57 0 2 1.00 
DD group 
No. at risk No. failed No. 
wi thdrawn 
Interval 
patency rate 
93 
88 
86 
84 
84 
Cumulat ive 
patency rate 
(%) 
4.1 
Standard 
error 
(%) 
0-1 95 14 5 0.84 84 
1-3 76 6 2 0.92 78 
3-6 68 1 3 0.99 77 
6-9 64 3 3 0.95 73 
9-12 58 2 4 0.96 71 4.9 
Life table 4. L imb salvage. 
Interval No. at risk 
(mo) 
No. failed 
ABI group 
No. 
wi thdrawn 
Interval 
patency rate 
Cumulat ive 
patency rate 
(%) 
Standard 
error 
(%1 
0-1 90 2 8 0.98 98 
1-3 80 3 4 0.96 94 
3-6 73 4 4 0.94 88 
6-9 65 0 4 1.00 88 
9-12 61 0 5 1.00 88 
DD group 
3.6 
Interval 
(mo) 
No. at risk No. failed No. Interval Cumulat ive 
wi thdrawn patency rate patency rate 
(%) 
Standard 
error 
(%) 
0-1 95 4 6 0.96 96 
1-3 85 5 4 0.94 90 
3-6 76 4 3 0.95 85 
6-9 69 2 2 0.97 83 
9-12 65 1 4 0.98 81 4.3 
Table 3. Management of duplex surveillance in 191 examinations. 
Type of radiologist n Mean number  Range % of all exams 
of exams 
Senior 7 15 1-50 57 
Trainee 15 6 1-14 43 
started at 1 month postoperatively did not affect pat- 
ency as the 1-year primary assisted patency for those 
patent at 1 month was 79% versus 77% (p = 0.91) and 
secondary patency for same group 90% versus 83% 
respectively (p = 0.27). 
Amputations 
The limb salvage rate was 88% in the ABI group versus 
81% in the DD group (p = 0.23) (Fig. 4). 
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Tab le  4. Completeness  o f  surve i l l ance  o f  g ra f ts  that  occ luded.  100 
90 ABI group DD group 
8O 
Total 7 12 
70 
Complete follow-up 2 7 
Intervention criteria neglected 0 1 60 
Other abnormality not 0 4 ~ 50 
included in intervention 40 
criterias 
30 
Incomplete follow-up 5 5 
Over 3 months from previous 5 0 20 
outpatient visit 10 
Previous control unsatisfactory 
Duplex not done 0 5 
ABI not measured 0 0 0 
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
(90) 
~ (6___L_) 
/ 
_ i .............. / (55) 
(68) ~,, L {49) (45) L 68% 
- (58) : . . . . . . . . . . . . . . . . . . . . .  , 
(52) 
. . . . . . . . . . . . . . . . . . . . . .  ; . . . . . . . . . . . . .  56% (45) 
I I 
1 2 
I I [ I I I I [ I I 1 I 
0 3 4 5 6 7 8 9 10 11 12 13 14 
Mouths postoperatively 
Fig. 1. Cumulative primary patency rate in the DD group is lower 
than in the ABI group, although the difference is not statistically 
significant (p=0.11). The difference in outcome reflects the higher 
number of immediate occlusions and also revisions done during 
the surveillance period. Number of patients at risk during different 
time intervals are shown in parenthesis. (--) ABI group; (...) DD 
group. 
Discussion 
Our results are in conflict with previous studies. In 
numerous tudies the benefits of grafts surveillance 
and subsequent intervention on graft patency has been 
reported. 12-14'2° Strong opinions that duplex scanning 
is the non-invasive investigation of choice have been 
expressed. However, there is no randomised controlled 
prospective trial to support his belief. 
Study design 
The study was embarked as a part of normal clinical 
practice of a single centre. Therefore the principles of 
treatment did not differ between groups. Patients with 
prosthetic grafts were excluded firstly because of their 
(90) 
~_ (71) 
I [ 
1 2 
(58) 
: I (52) (49) 
74% 
(62) (58) '- . . . . . . . . . . . . . . . . . . .  ~ . . . . . . . . . . . .  65% (52) 
I I I I I I I [ I I I I 
3 4 5 6 7 8 9 10 11 12 13 14 
Months postoperatively 
Fig. 2. Cumulative assisted primary patency in the ABI group and 
the DD group (p = 0.21). The higher amount of revisional procedures 
in the DD group did not have beneficial effect on outcome. Number 
of patients at risk during different time intervals are shown in 
parenthesis. (--) ABI group; (.-.) DD group. 
lOO 
90 
80 
70 
60 
50 
40 
30 
20 
lO 
(67) (61) 
' (57) 
I 84% 
(68) . . . . . . .  }64i .......... ! . . . . . . . . . . . . . . . . . . . . .  ,. . . . . . . . . . . . . . .  71~o 
(58) 
(90)  
(76) 
- I 
(76) 
I I I I I I I I I ] I I I I 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Months postoperatively 
Fig. 3. Cumulative secondary patency in the ABI and the DD 
group. The difference is statistically significant (p = 0.04). Number 
of patients at risk during different time intervals are shown in 
parenthesis. (--) ABI group; (...) DD group. 
100 
90 
8o L 
70--  
60 L 
50-  
40 -- 
30 
20' 
10 
(90) 
~9-~....!8.°L...., ~73) 
c65) [ ..................... ! (65) ~61) 68~ 
(76) ~ . . . . . . . . . . . . . . . . . . . . . .  
(69) . . . . . . . .  i ~ ;  . . . . . . . . .  ' . . . . . . . . . . . . . .  Sl~ 
I I I I I I I I I I ] I I 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Mouths postoperatively 
Limb salvage rates in the ABI group and the DD group. F ig .  4.  
Number of patients at risk during different ime intervals are also 
shown in parenthesis. (--) ABI group; (-.-) DD group. 
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low number which did not allow any meaningful 
statistical analysis, and secondly because there is evi- 
dence that Duplex scan surveillance ofprosthetic graft 
is not useful. 2~ The randomisation according to the 
day of birth has theoretical methodological pitfalls, 
but did not result in any dissimilarities between the 
two study groups as found by comparing patient 
characteristics. Indeed, comparing the groups showed 
them to be well-matched for preoperative, operation 
and surveillance data. Patient compliance was ac- 
ceptable with only four patients lost to follow-up in 
both groups. 
There were, however, difficulties in conducting the 
study. The percentage of visits was acceptable, but 
only 60% of duplex scans in the DD group were carried 
out as planned and in ABI group 8% of control visits 
included a duplex scan outside the study protocol. 
The duplex scans in the ABI group resulted in one 
patch angioplasty 2 months postoperatively. These 
figures can be explained firstly with patient com- 
pliance-related factors and secondly, with the fact that 
several surgeons who were not directly involved in 
this study were in charge of the outpatient visits. Due 
to this fact, clinical judgement occasionally overruled 
the study protocol. The degree of incompleteness and 
its impact on results is difficult o assess and compare 
to other studies as this kind of information rarely is 
reported. This should be addressed in future studies. 
Duplex scanning was also performed by whichever 
radiologist was in charge. This was a disadvantage 
and might have resulted in variations in duplex 
interpretations, but one aim in this study was to see 
how the surveillance program could be done in clinical 
practice. The level of awareness of clinical and duplex 
criteria need to be stressed very thoroughly for a 
surveillance program to succeed. A good alternative is 
to concentrate duplex surveillance toa few individuals, 
most appropriately tovascular technologists who are 
able to gather experience faster than radiologists or 
surgeons. 
Failing grafts 
Only three patients out of 17 with patency threatening 
stenoses were detected on basis of clinical signs (one 
in the ABI group and two in the DD group). This 
finding is in accordance with previous tudies in that 
60-90% of haemodynamically compromised grafts will 
be missed if symptoms only are used as an in- 
dicator. 22-25 All threatened grafts in the ABI group and 
6 out of 13 (46%) in the DD group had a decrease in 
ABI measurement of more than 0.15. This sensitivity 
figure is close to that found by other groups. 13'18"24-27 
Two patients in the DD group who had significant 
stenoses confirmed angiographically did not undergo 
revision. The decision not to intervene was made by 
the treating surgeon together with the patient. Neither 
of these grafts occluded uring 2 years follow-up. 
Occluded grafts 
A total of seven grafts in the ABI group and 12 grafts 
in the DD group occluded during follow-up period. 
This unexpected finding prompted an analysis of the 
completeness of the follow-up (Table 4). It was found 
that the time from last control visit to occlusion ex- 
ceeded 3 months in five patients in the ABI group but 
in no patients in DD group, which is also reflected as 
a longer mean duration from last outpatient to oc- 
clusion in the ABI group. Five patients in the DD 
group had not had duplex scanning at their previous 
visit. These findings also indicate that the follow-up 
program was not complete and may explain some of 
the occlusions in both groups. In the DD group a 
persistent low-flow state in one graft after revision 
was neglected with subsequent occlusion. In the ABI 
group one occlusion could be explained by a delay 
from outpatient visit to further examinations. 
Intervention criteria 
A decrease in ABI measurement of 0.15 compared to 
the immediate postoperative value was considered 
significant. The use of a 0.15 as the cut-off point is 
supported by our own analysis as well as aggregated 
data from several studies. 28 It has been shown that 
sensitivity of ABI measurement decreases from 75 to 
35% when the cut-off level for ABI decrease isincreased 
from 0.1 to 0.2. 23 Stierli et al. 23 detected all 12 failing 
grafts by using 0.1 as a cut-off level. They suggested 
ABI measurement as the primary examination for 
selecting patients requiring further analysis. Their 
finding has not been supported by other authors .  29'3° 
The problem with ABI measurement is its narrow 
diagnostic range. Fisher et al. 31 demonstrated that the 
95% confidence limits of variation in ABI measurement 
is _+0.21. In our own vascular laboratory maximum 
difference in33 patients studied by two vascular nurses 
was 0.14. 28 Therefore an ABI decrease of 0.15 seems to 
be the cut-off level of choice. 
Duplex criteria are also widely discussed. The mid- 
graft PSV <45 cm/s as a criteria for failing grafts was 
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introduced by Bandyk et al., 32 but later it has been 
demonstrated that considerable numbers of stenoses 
will be missed by using the above mentioned criteria 
only. 33 By combining high and low velocity criterias, 
as used also in this study, Taylor et al. 17 claimed a 
sensitivity of 100% and a specificity of 98% (V2/V1 
>2.0 and PSV <45 cm/s). Sladen et aI. I6 also reported 
a sensitivity of 98% and a specificity of 87% by com- 
bining PSV <45 cm/s with V2/V1 ratio >3.0 to detect 
significant stenoses. Buth et a135 suggested that end- 
diastolic velocity (EDV) >20 cm/s at a stenosis or a 
narrowest portion of the graft provides a good in- 
dicator for critical (>70%) stenoses. We could also find 
evidence supporting this fact in our own re-evaluation 
of the duplex protocols on grafts that failed. 
In conclusion, this study could not verify that sur- 
veillance based on duplex scanning leads to higher 
vein graft patency compared to more conventional 
surveillance. Thus there still is an urgent need for a 
large randomised prospective trial with strict ad- 
herence to study protocol. 
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Limb salvage 
The 1-year limb salvage rates were lower in the DD 
group. This result is in accordance with patency rates 
showing a clear tendency between the group which is 
mostly due to higher immediate occlusion rate in 
the DD group before the surveillance program was 
commenced. 
Duplex is a powerful tool for detecting stenoses and 
in this study it was more effective in finding stenoses 
thought o threaten graft patency. However, primary 
assisted or secondary patency rates in the DD group 
were no better than in the ABI group. This may indicate 
that the natural course and the value of prophylactic 
interventions of a stenosed graft is still not known. In 
a study by Mattos et al. 24 when grafts with stenoses 
detected by duplex were left untreated, the patency 
rate at i year was 66% compared to 96% in revised 
grafts. Also in Wilson's study 34 the secondary patency 
rate was lower at 1 year in a subgroup of untreated 
patients known to have stenosis, but the difference 
was not as significant (87.5% versus 75%). In these 
studies the decision whether to treat or not was made 
on clinical basis, so the groups were not directly 
comparable. The only randomised prospective study 
on graft surveillance TM followed patients for 3 years 
after surgery and reported patency rates following 
intervention in favour of an intensive surveillance 
program. However in that study graft occlusions were 
frequent in both groups probably due to study design 
and also the number of patients was rather small. One- 
month occlusion rate was 11%, which is in accordance 
with previous studies. 1-s We did not perform pre- 
discharge duplex scans. They could possibly have been 
valuable in avoiding some of the occlusions before the 
first outpatient visit. 
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